All Cases

Biopharma

Developed comprehensive Payer Portfolio Offerings, including Services and Payment Strategies in several emerging markets, including the Middle East, Gulf Countries, Saudi Arabia and LATAM​

Customized brand value proposition for Cardiology customer segments to inform key launch elements of a small Biotech’s first launched product

Developed a rare liver disease market landscape for an investment group looking to identify potential acquisition targets for an expansion to the U.S. market and performed commercial due diligence resulting in an acquisition of over $2B

Defined investment criteria, including the business model and P&L, allowing an investment management company seeking to expand their life sciences practice

Identified emotional drivers influencing treatment selection at specific points in the patient journey for a rare disease

Developed a market map to inform a mid-size GTx manufacturer’s commercial strategy and launch planning

Developed comprehensive approach to navigate international reimbursement for a GTx while managing channel-specific pricing considerations

Mapped key decisions and drivers of adoption for a blockbuster hematology product, informing strategic planning at a large pharmaceutical company looking to expand to new indications

Constructed a value proposition and IMSS (Mexico) access plan for a novel multiple sclerosis (MS) therapy

Identified and mapped KOLs and COEs, and assessed therapeutic approach and drivers of adoption to inform launch strategy for a mid-sized pharmaceutical company seeking to launch internationally